With passion and commitment, we provide innovative solutions in the field of nuclear medicine that serve to protect health, which is the highest value for us.


We are a company that best responds to the needs of domestic and foreign customers in the nuclear medicine industry. We combine many years of experience with modern technologies in order to maintain a significant position in the production of isotopes for medicine, science and industry.


The history of POLATOM begins in 1950-ties. In 1957 in the Institute of Nuclear Research was created a new department of isotope distribution, which two years later was transformed into Isotope Distribution Office.

The first success in production came in 1962.

1962- first medical preparations of iodine-131, suphur-35 and phosphorus-32.

1964 – standard solutions, reference sources, iodine-131 labelled preparations: hipurate, rose bengal, fibrinogen.

1968 – sealed sources for gamma – radiography.

1970’s – technetium-99m and indium-113m generators, scintigraphic kits, sodium iodide-131 in capsules, first radioimmunoassays.

1980’s – implementation of ISO standards in sealed sources for gamma – radiography, improvements of technologies with respect to environment protection.

1990’s – modernisation of technetium-99m generators, new generation of radioimmunoassays and immunoradiometric kits, new radiopharmaceuticals: 89SrCl2123I / 131I MIBG.

1994 – 1998 implementation of GMP for radiopharmaceutical production.

2001 – implementation of quality management system ISO 9001: 2000 and the WSK (Internal Control System).

2004 – 2005 Rhenium-188 generator.

2005 – production and commercial activity became speciality of new legal organisation: POLATOM